6.27
Cartesian Therapeutics Inc (RNAC) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
100.00%
-
|
0.078 | 0.947 | 0.452 | 0.298 |
| Operating Expenses |
9.70%
29.16
|
26.58 | 79.59 | 21.52 | 22.11 |
| Operating Income/Loss |
10.02%
-29.16
|
-26.50 | -78.64 | -21.07 | -21.81 |
| Nonoperating Income/Loss |
454.21%
44.92
|
-12.68 | - | - | - |
|
|
140.25%
15.77
|
-39.18 | -92.58 | -35.90 | 15.89 |
| Basic Average Shares |
9.73%
29.47
|
26.86 | 0.011 | 26.00 | 25.98 |
| Diluted Average Shares |
11.19%
29.86
|
26.86 | 0.011 | 26.00 | 26.45 |
| Basic Earnings Per Share |
132.19%
0.47
|
-1.46 | -3.57 | -1.38 | 0.51 |
| Diluted Earnings Per Share |
131.51%
0.46
|
-1.46 | -3.57 | -1.38 | 0.50 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
2.049
|
- | - | - | 2.628 |
자본화:
|
볼륨(24시간):